Literature DB >> 11232691

Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses.

S Elsenbruch1, W C Orr.   

Abstract

OBJECTIVE: As the primary link between brain and gut, autonomic and endocrine dysfunction may play a role in the pathophysiology of the irritable bowel syndrome (IBS). The aim of this study was to assess autonomic, endocrine, and symptomatic responses to food intake in diarrhea-predominant and constipation-predominant IBS patients, compared to normals.
METHODS: Twelve women with diarrhea-predominant or alternating IBS (IBS-D), 12 women with constipation predominant IBS (IBS-C), and 20 healthy women participated. GI symptoms, saliva cortisol concentration, heart rate, and heart rate variability were assessed at baseline and after a meal. Spectral analysis of heart rate variability was used as a measure of the sympathovagal regulation of the heart rate.
RESULTS: Both groups of IBS patients showed a significant postprandial increase in GI symptoms. IBS-D showed a significant increase in the low frequency/high frequency band ratio and a decrease in the high frequency band power during the first postmeal period, which was significantly different, not only from controls, but also from IBS-C. IBS-D also showed a significant postprandial increase in cortisol, which was not evident in controls or IBS-C. There was a significant correlation between the vagal response and the postprandial increase in GI symptoms in IBS-D (r = 0.6, p < 0.05).
CONCLUSIONS: These findings support the notion that the IBS symptom groups are characterized by different physiological responses to visceral stimuli, and point to a role of autonomic pathways in IBS symptomatology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11232691     DOI: 10.1111/j.1572-0241.2001.03526.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  35 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

2.  Increased beta-adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome.

Authors:  Jung Ho Park; Poong-Lyul Rhee; Hyun Seo Kim; Jun Haeng Lee; Young-Ho Kim; Jae Jun Kim; Jong Chul Rhee; Eun Ho Kang; Bum-Hee Yu
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 3.  Pharmacogenetics and the treatment of functional gastrointestinal disorders.

Authors:  Houssam Halawi; Michael Camilleri
Journal:  Pharmacogenomics       Date:  2017-07-07       Impact factor: 2.533

4.  Sex specific alterations in autonomic function among patients with irritable bowel syndrome.

Authors:  K Tillisch; E A Mayer; J S Labus; J Stains; L Chang; B D Naliboff
Journal:  Gut       Date:  2005-05-28       Impact factor: 23.059

5.  Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome.

Authors:  Monica E Jarrett; Robert L Burr; Kevin C Cain; Vicky Hertig; Pam Weisman; Margaret M Heitkemper
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

6.  Autonomic function at rest and in response to emotional and rectal stimuli in women with irritable bowel syndrome.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

7.  Current insights in to the pathophysiology of Irritable Bowel Syndrome.

Authors:  Theodoros Karantanos; Theofano Markoutsaki; Maria Gazouli; Nicholas P Anagnou; Dimitrios G Karamanolis
Journal:  Gut Pathog       Date:  2010-05-13       Impact factor: 4.181

8.  Neuroendocrine markers and psychological features in patients with irritable bowel syndrome.

Authors:  Cristina Stasi; Massimo Bellini; Francesco Costa; Maria Gloria Mumolo; Angelo Ricchiuti; Mariano Grosso; Emiliano Duranti; Maria Rosaria Metelli; Dario Gambaccini; Lea Bianchi; Gian Luca Di Tanna; Giacomo Laffi; Stefano Taddei; Santino Marchi
Journal:  Int J Colorectal Dis       Date:  2013-02-02       Impact factor: 2.571

9.  Catecholamine and cortisol levels during sleep in women with irritable bowel syndrome.

Authors:  R L Burr; M E Jarrett; K C Cain; S-E Jun; M M Heitkemper
Journal:  Neurogastroenterol Motil       Date:  2009-07-01       Impact factor: 3.598

10.  Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome.

Authors:  L Chang; S Sundaresh; J Elliott; P A Anton; P Baldi; A Licudine; M Mayer; T Vuong; M Hirano; B D Naliboff; V Z Ameen; E A Mayer
Journal:  Neurogastroenterol Motil       Date:  2008-08-05       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.